127 related articles for article (PubMed ID: 9490466)
21. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
22. [The internist and ovarian cancer].
Salvatore AJ; Urga PA; Caprarulo L; Maxit MJ
Medicina (B Aires); 1998; 58(5 Pt 1):458-62. PubMed ID: 9922476
[TBL] [Abstract][Full Text] [Related]
23. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
[TBL] [Abstract][Full Text] [Related]
24. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL
Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
Provenza C; Young RH; Prat J
Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
[TBL] [Abstract][Full Text] [Related]
26. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
28. The management of women with apparent early ovarian cancer in the south-west region of England.
Olaitan A; Murdoch J; Weeks J; James J; Howe K
J Obstet Gynaecol; 2002 Jul; 22(4):394-8. PubMed ID: 12521463
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of women with metachronous breast and ovarian carcinomas.
Liou WS; Hamilton CA; Cheung MK; Osann K; Longacre TA; Teng NN; Husain A; Dirbas FM; Chan JK
Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of clear cell carcinoma of the ovary.
Behbakht K; Randall TC; Benjamin I; Morgan MA; King S; Rubin SC
Gynecol Oncol; 1998 Aug; 70(2):255-8. PubMed ID: 9740700
[TBL] [Abstract][Full Text] [Related]
31. Even young patients with no alarm symptoms should undergo endoscopy for earlier diagnosis of gastric cancer.
Bołdys H; Marek TA; Wanczura P; Matusik P; Nowak A
Endoscopy; 2003 Jan; 35(1):61-7. PubMed ID: 12510228
[TBL] [Abstract][Full Text] [Related]
32. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
[TBL] [Abstract][Full Text] [Related]
34. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.
Vine MF; Ness RB; Calingaert B; Schildkraut JM; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):466-71. PubMed ID: 11733956
[TBL] [Abstract][Full Text] [Related]
35. Symptoms of ovarian cancer in young patients 2 years before diagnosis, a case-control study.
Behtash N; Ghayouri Azar E; Fakhrejahani F
Eur J Cancer Care (Engl); 2008 Sep; 17(5):483-7. PubMed ID: 18537813
[TBL] [Abstract][Full Text] [Related]
36. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
37. Occult bilateral involvement in stage I epithelial ovarian cancer.
Benjamin I; Morgan MA; Rubin SC
Gynecol Oncol; 1999 Mar; 72(3):288-91. PubMed ID: 10053097
[TBL] [Abstract][Full Text] [Related]
38. Symptoms attributed to ovarian cancer by women with the disease.
Igoe BA
Nurse Pract; 1997 Jul; 22(7):122, 127-8, 130 passim. PubMed ID: 9253020
[TBL] [Abstract][Full Text] [Related]
39. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
